[1] |
SUN Ming-lei1, XIE Wei-hong1, WANG Chang-mei2, WEN Yu-ming2.
Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph node metastasis
[J]. West China Journal of Stomatology, 2011, 29(03): 253-256.
|
[2] |
SUN Ming-lei1, WANG Chang-mei2, WEN Yu-ming2.
Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro
[J]. West China Journal of Stomatology, 2010, 28(03): 257-260.
|
[3] |
SHOU Bo -quan, MAO Zhao, ZHANG Shen-lin, YANG Zhen.
Allergy caused by minidose and low concentration Pingyangmycin: A case report
[J]. West China Journal of Stomatology, 2009, 27(05): 572-573.
|
[4] |
WU Jun-lou1, LIANG Xin-hua2, MAO Zu-yi2, XIAO Gui-zhou3.
Relationship between Nuclear Factor Kappa B Signal Transduction Way and the Sensitivity of Tongue Carcinoma Cell to Pingyangmycin Chemotherapy
[J]. West China Journal of Stomatology, 2006, 24(05): 451-454.
|
[5] |
GAO Qing-hong1,ZHENG Gen-jian2,WANG Chang-guang3,ZHOU Lan2,WEN Yu-ming1,WANG Chang-mei1, HOUShi-xiang3.
An Experimental Study on the Preparation and Drug Sustained Release Characteristics of Pingyangmycin Albumin Micro- spheres
[J]. West China Journal of Stomatology, 2005, 23(01): 69-71.
|
[6] |
Ming-lei1,WEN Yu-ming2, WANG Chang-mei2, LILong-jiang2, WANGXiao-yi2.
Preparation of Lymphatic Targeting Dosage Form: Pingyangmycin Absorbed on Activated Carbon Nanoparticles
[J]. West China Journal of Stomatology, 2004, 22(03): 183-185.
|
[7] |
.
[J]. West China Journal of Stomatology, 2003, 21(04): 333-333.
|
[8] |
Gao Qinghong, Wang Changmei, Wen Yuming, et al.
A Study of Effects of Pingyangmycin Injection on Treatment of Lymphangiomas in Oral, Maxillofacial and Cervical Regions
[J]. West China Journal of Stomatology, 2002, 20(03): 184-186.
|
[9] |
.
[J]. , 2001, 19(03): 0-.
|
[10] |
.
[J]. , 2001, 19(03): 0-.
|
[11] |
.
[J]. , 1996, 14(03): 0-.
|
[12] |
.
[J]. , 1996, 14(02): 0-.
|